Tag:
Bradmer Pharmaceuticals
Latest Headlines
Latest Headlines
Bradmer cuts staff, ends trial enrollment
With a financial earthquake shaking up the ranks of the world's biotech companies, Bradmer Pharmaceuticals has opted to cut back as it loses hope in finding new operating capital. Bradmer is cutting
Bradmer triggers strategic review on trial delay
Canada's Bradmer Pharmaceuticals has run into a serious snag that is triggering a strategic review. In a release out this morning, the developer says the CRO it hired for a late-stage brain cancer
